Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESCUE: NDV-01 in Non-muscle Invasive Bladder Cancer
NCT07464145Phase 3Not yet recruiting
- Sponsor
- Relmada Therapeutics, Inc.
- Start
- Feb 2027
- Primary completion
- Dec 2029
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of NDV-01 in non-muscle-invasive bladder cancer (NMIBC), sponsored by Relmada Therapeutics, Inc.. Planned start Feb 2027; status: not yet recruiting.
02
Drugs
NDV-01
03
Conditions
non-muscle-invasive bladder cancer (NMIBC)
Beyond the preview
Go deeper on NCT07464145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07464145.